Literature DB >> 8065408

Risks and benefits of antiarrhythmic therapy.

D M Roden1.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 8065408     DOI: 10.1056/NEJM199409223311207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  Pharmacological Therapy of Cardiac Arrhythmias.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-11       Impact factor: 2.300

2.  Efficacy and safety of intravenous amiodarone in recent-onset atrial fibrillation: experience in patients admitted to a general internal medicine department.

Authors:  Y Kreiss; Y Sidi; H Gur
Journal:  Postgrad Med J       Date:  1999-05       Impact factor: 2.401

Review 3.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

4.  Electrophysiological Changes of the Atrium in Patients with Lone Paroxysmal Atrial Fibrillation.

Authors:  David K Murdock; James Reiffel; Jeff Kaliebe; German Larrain
Journal:  J Atr Fibrillation       Date:  2010-08-23

5.  Comparison of the Length of Hospital Stay between the Patients with Atrial Fibrillation Treated with Amiodarone and Patients with Normal Sinus Rhythm after Coronary Artery Bypass Graft.

Authors:  Samad Shams Vahdati; Jahanbakhsh Samadikhah; Seied Hadi Hakim; Rasoul Azarfarin; Mahsa Ansarin
Journal:  J Cardiovasc Thorac Res       Date:  2012-02-17

Review 6.  Amiodaron in atrial fibrillation: post coronary artery bypass graft.

Authors:  Paria Habibollahi; Shahrzad Hashemi Jam; Samad Shams Vahdati; Hamidreza Morteza Baghi; Hassan Amiri
Journal:  World J Emerg Med       Date:  2016

7.  The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience with implications for possible "pill in the pocket" approach to atrial fibrillation.

Authors:  David K Murdock; Mary Kersten; Jeff Kaliebe; German Larrain
Journal:  Indian Pacing Electrophysiol J       Date:  2009-09-01

Review 8.  [Pre-clinical management of shock patients].

Authors:  F Christ; Chr K Lackner
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

Review 9.  Cardiac arrhythmias in the human fetus.

Authors:  C S Kleinman; R A Nehgme
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

Review 10.  Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal.

Authors:  A Capucci; G Boriani
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.